UT Health San Antonio School of Dentistry lab leads with digital automation for patient care
June 21, 2022
Technicians create prosthetics using cutting-edge CAD/CAM system Contact: Steven Lee, 210-450-3823, lees22@uthscsa.edu SAN ANTONIO – A lab at the UT Health San Antonio School of Dentistry is using leading computer-aided automation that includes a partn …
Andrea Marks recognized with leadership award
June 20, 2022
The San Antonio Business Journal recently released its list of honorees for the 2022 Women’s Leadership Awards, recognizing Andrea Marks, MBA, CPA, senior executive vice president and chief operating officer, as an outstanding leader in the community.
UTPD announces new Mental Health Unit
June 20, 2022
In response to the growing need for mental health resources and assistance in our community, the UT Police Department is pleased to announce the formation of a Mental Health Unit.
UT Health San Antonio surgical oncologist co-authors NEJM article showing disparity in Black breast cancer mortality
June 20, 2022
Deaths nearly 40% higher than for white women, pegged to lower access to care Contact: Steven Lee, 210-450-3823, lees22@uthscsa.edu SAN ANTONIO – Black women die of breast cancer at rates nearly 40% higher than white women, despite having lower instanc …
Mays Cancer Center featured for its value to the region’s population and economy
June 17, 2022
In a special section of the June 17, 2022, San Antonio Business Journal, experts from Mays Cancer Center at UT Health San Antonio discuss the broad scope of cancer patient care and lifesaving research taking place daily at the center and its value to the local community and regional economy.
Novel brain injury treatment tested in 1st human subject
June 17, 2022
An experimental brain injury medication conceived in laboratories at UT Health San Antonio was tested Tuesday, June 14, in the first human subject. If the drug, called AST-004, performs well in human studies, it will be an urgently needed and novel treatment for stroke and traumatic brain injury victims, including those with concussions.
San Antonio Business Journal: The new cancer quest and what it means for San Antonio
June 17, 2022
Drs. Ruben Mesa, Kate Lathrop and Mark Bonnen of the Mays Cancer Center took part in a panel discussion for this story. Read More
San Antonio Express-News: San Antonio scientist’s novel brain injury drug being tested in humans
June 17, 2022
Dr. James Lechleiter, Cell Systems and Anatomy, is featured in this story. Read More
KSAT 12: COVID-19 worsening in San Antonio as FDA advisers move forward with vaccine for children under 5
June 16, 2022
Dr. Mandie Svatek, Pediatrics, was interviewed for this story. Read More
Yahoo! Finance: Novel brain injury treatment tested in 1st human subject; drug conceived at UT Health San Antonio
June 16, 2022
James D. Lechleiter, PhD, professor of cell systems and anatomy at UT Health San Antonio, and Andrea Giuffrida, PhD, vice president for strategic industry ventures at UT Health San Antonio, were quoted in this story about the first human test of experi …